How AI and QSAR Modeling Accelerate Ligand-Based Drug Design https://www. byteseu.com/2010510/ # AI # ArtificialIntelligence # DrugDiscovery # LigandBasedDrugDe
The article explores how artificial intelligence, specifically Quantitative Structure-Activity Relationship (QSAR) modeling, is revolutionizing ligand-based drug design. By leveraging AI, researchers can more efficiently identify and develop potential drug candidates. This approach speeds up the discovery process, moving towards more precise and personalized medicine. AI
IMPACT Accelerates the identification and development of potential drug candidates, moving towards more precise medicine.